# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(2.90) per share. This is a 127.37 percent decrease over earning...